Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Understanding Rare Conditions: The Multifaceted Financial Impact

January 26, 2023

More than a third of Health Union’s Myasthenia Gravis In America 2022 survey respondents said their condition has negatively impacted their finances.

Bringing Patient Centricity to Life: Health Union’s Social Health Network

December 7, 2022

Health Union's Social Health Network builds health leaders into confident and trustworthy partners for the healthcare industry. Here's why that matters.

Patient and Caregiver Perspectives: How Pharma Can Improve the Chronic Condition Experience

November 30, 2022

Two health leaders share wins, challenges and opportunities they've faced as patient and caregiver to help pharma improve the chronic condition experience.

Understanding Rare Conditions: Support & Connection

November 8, 2022

The internet has allowed people living with chronic conditions to find information, connection and support that might not have been readily available.

Parkinson’s Disease Patient-Reported Survey Data

November 23, 2020

New Health Union survey data reveals interesting differences in the patient journeys of men and women living with Parkinson’s disease.

Spondyloarthritis Patient-Reported Survey Data

November 18, 2020

Survey data uncovers the often difficult spondyloarthritis diagnosis journey, showing that 83% of respondents with nr-AxSpA were initially misdiagnosed.

Sleep Disorders Patient-Reported Survey Data

November 10, 2020

People living with sleep disorders like sleep apnea, RLS, insomnia and narcolepsy share their experiences in new survey data from Health Union.

5 Things Patient Advocates Want Pharma to Know

November 9, 2020

Presented with Health Union’s trusted survey data from tens of thousands of people, chronic health patient advocates share what they want pharma to know.

Healthcare Industry Thought Leadership

Contact